Feb 9th, 2021
Tilray CEO on Grow Deal, Aphria Merger, Pot Legalization
Tilray CEO Brendan Kennedy discusses the pact with Grow Pharma to distribute Tilray's medical cannabis products in the U.K., the agreed merger with Aphria, and the outlook for U.S. legalization of marijuana on "Bloomberg Markets: The Close." (Source: Bloomberg)







